Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year.

Literature DB >> 4144533

The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year.

P Riis, P Anthonisen, H R Wulff, O Folkenborg, O Bonnevie, V Binder.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Placebos
Sulfasalazine

Year: 1973 PMID： 4144533

Source DB: PubMed Journal: Scand J Gastroenterol ISSN： 0036-5521 Impact factor: 2.423

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II.

Authors: R G Shorter; D A Shephard
Journal: Am J Dig Dis Date: 1975-07

2. Meta-analysis of the placebo response in ulcerative colitis.

Authors: Sagar Garud; Alphonso Brown; Adam Cheifetz; Emily B Levitan; Ciaran P Kelly
Journal: Dig Dis Sci Date: 2007-10-13 Impact factor: 3.199

Review 3. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.

Authors: Siddharth Singh; Joseph D Feuerstein; David G Binion; William J Tremaine
Journal: Gastroenterology Date: 2018-12-18 Impact factor: 22.682

Review 4. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.

Authors: Cynthia W Ko; Siddharth Singh; Joseph D Feuerstein; Corinna Falck-Ytter; Yngve Falck-Ytter; Raymond K Cross
Journal: Gastroenterology Date: 2018-12-18 Impact factor: 22.682

5. Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment.

Authors: K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal: Gut Date: 1988-10 Impact factor: 23.059

10. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

Authors: A S Dissanayake; S C Truelove
Journal: Gut Date: 1973-12 Impact factor: 23.059

The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year.

1. Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II.

2. Meta-analysis of the placebo response in ulcerative colitis.

Review 3. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.

Review 4. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.

5. Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment.

6. Salicylazosulfapyridine in inflammatory bowel disease.

7. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

8. Treatment of ulcerative colitis.

9. Molecular mechanisms of sulfasalazine-induced T-cell apoptosis.

10. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).